# Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity

> **NCT07021937** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 120 (estimated)

## Conditions studied

- Obesity/Therapy

## Interventions

- **DRUG:** Semaglutide 1.7mg subcutaneous
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07021937
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2031-04-30
- **Final completion:** 2031-04-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-06-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07021937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07021937, "Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07021937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*